<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04566237</url>
  </required_header>
  <id_info>
    <org_study_id>RLX_2020_26</org_study_id>
    <nct_id>NCT04566237</nct_id>
  </id_info>
  <brief_title>Objective Measurements of the Opacification of the Lens After Vitrectomy</brief_title>
  <acronym>MOCVIT</acronym>
  <official_title>Objective Measurements of the Opacification of the Lens After Vitrectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondation Ophtalmologique Adolphe de Rothschild</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fondation Ophtalmologique Adolphe de Rothschild</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cataract is the opacification of the lens. Usually cataract occurs slowly, causing&#xD;
      progressive vision loss over several months or years.&#xD;
&#xD;
      In ophthalmic clinical practice, repeated objective quantitative measurements of lens opacity&#xD;
      may be necessary to document its progression and support a surgical indication.&#xD;
&#xD;
      The subjective methods of evaluating the opacification of the lens have limitations, in&#xD;
      particular due to the lack of reproducibility between observers. Thus, innovative objective&#xD;
      techniques with precise and reproducible cataract classification results have been developed,&#xD;
      such as the Objective Scatter Index (OSI) on the Optical Quality Analysis System (OQAS),&#xD;
      Visiometrics SL in 2010 and, more recently, Average Lens Density (ALD) on the IOLMaster® 700&#xD;
      device. Cataract is diagnosed as mature when the OSI is ≥ 2 and / or when the ALD is ≥ 74&#xD;
      pixel units.&#xD;
&#xD;
      Vitrectomy is a surgery of the posterior segment of the eye indicated for retinal detachment,&#xD;
      epimacular membranes, macular holes, vitreous hemorrhage. The incidence of post-vitrectomy&#xD;
      cataract varies among studies, and the methodology is often retrospective. Age has already&#xD;
      been identified as a risk factor for progression since in a study of 28 eyes of patients&#xD;
      under 50 years old, only 7% developed cataracts secondarily, compared to 79% in the 'over 50'&#xD;
      group.&#xD;
&#xD;
      To date, there is no prospective study describing the progression kinetics of lens&#xD;
      opacification according to precise and reproducible quantitative objective criteria in&#xD;
      patients treated by vitrectomy. It also involves confirming the age and preoperative lens&#xD;
      status as a risk factor for postoperative cataract progression.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 21, 2020</start_date>
  <completion_date type="Anticipated">October 2024</completion_date>
  <primary_completion_date type="Anticipated">October 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in ALD value between baseline and 12 months after the intervention</measure>
    <time_frame>Baseline and 12 months after vitrectomy</time_frame>
    <description>ALD value : quantitative variable expressed in pixel units</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Vitrectomy</condition>
  <condition>Cataract</condition>
  <arm_group>
    <arm_group_label>24 months follow up after vitrectomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Objective Scatter Index (OSI) and Average Lens Density (ALD) at inclusion, then 3 months, 12 months and 24 months after vitrectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Objective Scatter Index (OSI)</intervention_name>
    <description>On Optical Quality Analysis System (OQAS) device. At Inclusion, 3 months, 12 months and 24 months after vitrectomy</description>
    <arm_group_label>24 months follow up after vitrectomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Average Lens Density (ALD)</intervention_name>
    <description>on IOLMaster® 700 device. At Inclusion, 3 months, 12 months and 24 months after vitrectomy</description>
    <arm_group_label>24 months follow up after vitrectomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient over 18 years old&#xD;
&#xD;
          -  Indication for unilateral 3-way vitrectomy for retinal detachment, macular hole,&#xD;
             epiretinal membrane, vitreous hemorrhage&#xD;
&#xD;
          -  Bilateral phakic patient&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Vitrectomy combined with cataract surgery&#xD;
&#xD;
          -  Pregnant or breastfeeding woman&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Raphaël LEJOYEUX, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpital Fondation A. de Rothschild</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Amélie YACHITZ, MD</last_name>
    <phone>(0)148036454</phone>
    <phone_ext>+33</phone_ext>
    <email>ayavchitz@for.paris</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Raphaël LEJOYEUX, MD</last_name>
    <email>rlejoyeux@for.paris</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hôpital Fondation A. de Rothschuld</name>
      <address>
        <city>Paris</city>
        <zip>75019</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raphaël LEJOYEUX</last_name>
      <email>rlejoyeux@for.paris</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>September 17, 2020</study_first_submitted>
  <study_first_submitted_qc>September 25, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 28, 2020</study_first_posted>
  <last_update_submitted>October 4, 2021</last_update_submitted>
  <last_update_submitted_qc>October 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Objective Scatter Index (OSI)</keyword>
  <keyword>Optical Quality Analysis System (OQAS)</keyword>
  <keyword>Average Lens Density (ALD)</keyword>
  <keyword>IOLMaster® 700</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

